Minocycline Susceptibility and tetB Gene in Carbapenem-Resistant Acinetobacter baumannii in Taiwan
- PMID: 35528186
- PMCID: PMC9075780
- DOI: 10.2147/IDR.S357344
Minocycline Susceptibility and tetB Gene in Carbapenem-Resistant Acinetobacter baumannii in Taiwan
Abstract
Purpose: In this study, we evaluated the minocycline susceptibility rate in carbapenem-resistant Acinetobacter baumannii (CRAB) clinical strains, and the association between tetB carriage and minocycline susceptibility in CRAB.
Patients and methods: A total of 100 genetically unrelated CRAB clinical strains from bloodstream infection were randomly collected from a medical center in Taiwan. An argument for a new minocycline susceptibility breakpoint of 1 mg/L was suggested based on pharmacokinetic (PK) and pharmacodynamic (PD) studies. Strains with minocycline minimum inhibitory concentrations (MICs) of >1 mg/L were classified as PK-PD non-susceptible. TetB carriage was detected by polymerase chain reaction (PCR).
Results: Fifty-five (55%) CRAB strains were susceptible to minocycline according to the Clinical and Laboratory Standards Institute (CLSI) criteria, among which 98.2% (54/55) were PK-PD non-susceptible. The minocycline MIC50/90 was 4/16 mg/L. Ninety-seven (97%) strains carried tetB. All of the tetB-positive strains and 66.7% (2/3) of the tetB-negative strains were PK-PD non-susceptible. By statistical analysis, tetB carriage was significantly correlated with PK-PD non-susceptibility (P = 0.03) and a higher minocycline MIC (P = 0.02). The sensitivity and specificity of the tetB PCR for predicting PK-PD non-susceptibility were 98% and 100%, respectively.
Conclusion: At our institute, most CRAB strains were PK-PD non-susceptible and most carried tetB gene. Recognizing the minocycline MIC and tetB status may be essential when using minocycline to treat CRAB-related infections.
Keywords: CRAB; efflux; minocycline PK-PD non-susceptibility; multidrug resistance.
© 2022 Yang et al.
Conflict of interest statement
The authors report no conflicts of interest in this work.
Figures
Similar articles
-
Minocycline Susceptibility of Carbapenem-Resistant Acinetobacter baumannii Blood Isolates from a Single Center in Korea: Role of tetB in Resistance.Infect Chemother. 2025 Mar;57(1):111-118. doi: 10.3947/ic.2024.0110. Infect Chemother. 2025. PMID: 40183657 Free PMC article.
-
Absence of TetB identifies minocycline-susceptible isolates of Acinetobacter baumannii.Int J Antimicrob Agents. 2018 Sep;52(3):404-406. doi: 10.1016/j.ijantimicag.2018.04.006. Epub 2018 Apr 14. Int J Antimicrob Agents. 2018. PMID: 29665446
-
[Prevalence of the tetA and tetB genes as mechanisms of resistance to tetracycline and minocycline in Acinetobacter baumannii clinical isolates].Enferm Infecc Microbiol Clin. 2006 Feb;24(2):77-80. doi: 10.1157/13085012. Enferm Infecc Microbiol Clin. 2006. PMID: 16545313 Spanish.
-
Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an In Vitro Pharmacodynamic Model.Antimicrob Agents Chemother. 2021 Feb 17;65(3):e01680-20. doi: 10.1128/AAC.01680-20. Print 2021 Feb 17. Antimicrob Agents Chemother. 2021. PMID: 33318006 Free PMC article.
-
Comparative evaluation of minocycline susceptibility testing methods in carbapenem-resistant Acinetobacter baumannii.Int J Antimicrob Agents. 2016 Sep;48(3):321-3. doi: 10.1016/j.ijantimicag.2016.05.017. Epub 2016 Jul 7. Int J Antimicrob Agents. 2016. PMID: 27451087
Cited by
-
Minocycline Susceptibility of Carbapenem-Resistant Acinetobacter baumannii Blood Isolates from a Single Center in Korea: Role of tetB in Resistance.Infect Chemother. 2025 Mar;57(1):111-118. doi: 10.3947/ic.2024.0110. Infect Chemother. 2025. PMID: 40183657 Free PMC article.
-
The Prevalence of Antibiotic Resistance Phenotypes and Genotypes in Multidrug-Resistant Bacterial Isolates from the Academic Hospital of Jaén, Spain.Antibiotics (Basel). 2024 May 9;13(5):429. doi: 10.3390/antibiotics13050429. Antibiotics (Basel). 2024. PMID: 38786157 Free PMC article.
-
The challenges of difficult-to-treat Acinetobacter infections.Clin Microbiol Rev. 2024 Dec 10;37(4):e0009324. doi: 10.1128/cmr.00093-24. Epub 2024 Nov 18. Clin Microbiol Rev. 2024. PMID: 39555919 Review.
References
-
- Flamm RK, Shortridge D, Castanheira M, Sader HS, Pfaller MA. In vitro activity of minocycline against U.S. Isolates of Acinetobacter baumannii-Acinetobacter calcoaceticus species complex, Stenotrophomonas maltophilia, and Burkholderia cepacia complex: results from the SENTRY Antimicrobial Surveillance Program, 2014 to 2018. Antimicrob Agents Chemother. 2019;63(11):e01154–e011519. doi:10.1128/AAC.01154-19 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources